BSX:NYSE
Boston Scientific Corp
$42.38
arrow_downward
-0.05%(-0.020) 1D
Oct 6, 12:19:24 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BSX...
Open
$42.47
High
$42.75
Low
$42.21
Mkt. cap
61.75B
Avg. vol.
20.59M
Volume
3.74M
P/E ratio
17.20
52-wk high
$105.65
52-wk low
$41.94
EPS
$2.47
Beta
0.58
Shares outstanding
1.45B
No. of employees
59K
Open
$42.47
High
$42.75
Low
$42.21
Mkt. cap
61.75B
Avg. vol.
20.59M
Volume
3.74M
P/E ratio
17.20
52-wk high
$105.65
52-wk low
$41.94
EPS
$2.47
Beta
0.58
Shares outstanding
1.45B
No. of employees
59K
News stories
From web sources and news partners
AD HOC NEWS
·
45 minutes ago
Boston Scientific stock heads toward an October 28 outlook reset in 2026
AD HOC NEWS
·
1 hour ago
Bernstein cuts Boston Scientific stock target from USD 60 to USD 54
AD HOC NEWS
·
1 day ago
Oppenheimer cuts target for Boston Scientific stock from USD 85.00 to USD 65.00
Investing.com
·
1 day ago
Bernstein cuts Boston Scientific stock price target on device competition
Profile
Boston Scientific Corporation is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
The company is known for developing the Taxus Stent, a drug-eluting stent that is used to open clogged arteries.
BSC is headquartered in Marlborough, Massachusetts and incorporated in Delaware. Wikipedia
About Boston Scientific Corp
CEOMichael F. Mahoney
Employees59K
FoundedJun 29, 1979
HeadquartersMarlborough, Massachusetts, United States
SectorMedical device
Websitebostonscientific.com